Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients Managed with an active drug.
From 18 Years to 99 Years.
i. Adult ≥ 18 years old
ii. Has provided written informed consent allowing the use of their data for the study and
providing permission for contact by the study personnel.
iii. Diagnosed with PCa.
iv. Prescribed Lupron as part of his treatment by his treating physician.
i. Patient cannot or will not sign informed consent.
ii. Presence of other condition that, in the opinion of the treating physician, prohibits
the patient from participating in the study or obscures the assessment of the treatment of
iii. More than 6 months of therapy if currently on continuous Luteinizing hormone-releasing
hormone (LHRH) treatment.
iv. If at study enrollment the intent is to only prescribe 1 dose of Lupron (leuprolide